People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,344.50GBp
31 Jul 2014
Price Change (% chg)

-13.00p (-0.30%)
Prev Close
4,357.50p
Open
4,366.00p
Day's High
4,395.50p
Day's Low
4,311.00p
Volume
4,937,363
Avg. Vol
3,435,109
52-wk High
4,946.41p
52-wk Low
3,085.21p

Search Stocks

Mallon, Mark 

Brief Biography

Mr. Mark Mallon is the Executive Vice President, International of AstraZeneca PLC., since January 2013 and is responsible for the growth and performance of AstraZeneca’s commercial businesses in regions including Asia Pacific, Russia, Latin America, the Middle East and Africa. Since joining AstraZeneca in 1994, Mark has held a number of senior sales and marketing roles including Regional Vice-President for Asia Pacific, President of AstraZeneca China and head of marketing, sales and commercial operations for AstraZeneca in Japan. Mark has a degree in chemical engineering from the University of Pennsylvania and an MBA in marketing and finance from the Wharton School of Business.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leif Johansson

318,000

Pascal Soriot

1,627,000

Marc Dunoyer

--

Lynn Tetrault

--

Ruud Dobber

--

Paul Hudson

--
As Of 30 Dec 2012
Search Stocks